Organization Overview
Alternative names
bifidobacterium breve (1 trial)
bifidobacterium infantis (1 trial)
bifidobacterium longum (1 trial)
capecitabine (xeloda) (1 trial)
fluconazole (diflucan) (1 trial)
Lactobacillus acidophilus (3 trials)
lactobacillus casei (2 trials)
Acquired Immunodeficiency Syndrome (Phase 3)
Birth Weight (Phase 3)
Brain Diseases (Phase 3)
Breast Neoplasms (Phase 3)
Candidiasis (Phase 3)
Candidiasis, Vulvovaginal (Phase 3)
Carcinoma (Phase 3)
Carcinoma, Hepatocellular (Phase 3)
Cholera (Phase 4)
Communicable Diseases (Phase 3)
Coronavirus Infections (Phase 3)
Death (Phase 3)
Diabetes Mellitus (Phase 3)
Diarrhea (Phase 3)
Dysentery (Phase 2)
Dyspepsia (Phase 2)
Encephalitis (Phase 2)
Encephalitis, Japanese (Phase 2)
Fibrosis (Phase 3)
Gastroenteritis (Phase 2)
Hepatic Encephalopathy (Phase 3)
HIV Infections (Phase 3)
Hypersensitivity (Phase 4)
Infections (Phase 3)
Insulin Resistance (Phase 4)
Irritable Bowel Syndrome (Phase 3)
Liver Diseases (Phase 3)
Meningitis (Phase 3)
Parasitic Diseases (Phase 4)
Pneumonia (Phase 3)
Pulmonary Fibrosis (Phase 3)
Respiratory Tract Infections (Phase 3)
Severe Acute Respiratory Syndrome (Phase 3)
Spinal Cord Injuries (Phase 2)
Syndrome (Phase 3)
Tuberculosis (Phase 3)
Tuberculosis, Pulmonary (Phase 3)
Vibrio Infections (Phase 2)
Virus Diseases (Phase 3)
Vitamin D Deficiency (Phase 3)
Wounds and Injuries (Phase 2)